Nasu H - Search Results

1

Development of sedentary communities in the Maya lowlands: coexisting mobile groups and public ceremonies at Ceibal, Guatemala.

Inomata T, MacLellan J, Triadan D, Munson J, Burham M, Aoyama K, Nasu H, Pinzón F, Yonenobu H. Inomata T, et al. Among authors: nasu h. Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):4268-73. doi: 10.1073/pnas.1501212112. Epub 2015 Mar 23. Proc Natl Acad Sci U S A. 2015. PMID: 25831523 Free PMC article.

2

High-precision radiocarbon dating of political collapse and dynastic origins at the Maya site of Ceibal, Guatemala.

Inomata T, Triadan D, MacLellan J, Burham M, Aoyama K, Palomo JM, Yonenobu H, Pinzón F, Nasu H. Inomata T, et al. Among authors: nasu h. Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):1293-1298. doi: 10.1073/pnas.1618022114. Epub 2017 Jan 23. Proc Natl Acad Sci U S A. 2017. PMID: 28115691 Free PMC article.

3

Monumental architecture at Aguada Fénix and the rise of Maya civilization.

Inomata T, Triadan D, Vázquez López VA, Fernandez-Diaz JC, Omori T, Méndez Bauer MB, García Hernández M, Beach T, Cagnato C, Aoyama K, Nasu H. Inomata T, et al. Among authors: nasu h. Nature. 2020 Jun;582(7813):530-533. doi: 10.1038/s41586-020-2343-4. Epub 2020 Jun 3. Nature. 2020. PMID: 32494009

4

Beginning of pig management in Neolithic China: comparison of domestication processes between northern and southern regions.

Hongo H, Kikuchi H, Nasu H. Hongo H, et al. Among authors: nasu h. Anim Front. 2021 Jun 19;11(3):30-42. doi: 10.1093/af/vfab021. eCollection 2021 May. Anim Front. 2021. PMID: 34158987 Free PMC article. No abstract available.

5

Preliminary study of standardized semiquantitative method for ultrasonographic breast composition assessment.

Uematsu T, Nakashima K, Nasu H, Igarashi T, Okayama Y, Notsu A. Uematsu T, et al. Among authors: nasu h. J Med Ultrason (2001). 2024 May 3. doi: 10.1007/s10396-024-01463-7. Online ahead of print. J Med Ultrason (2001). 2024. PMID: 38702497

6

Association of Chemotherapy Response Score with Multidrug Resistance 1 and CA125 ELIMination Rate Constant K in Patients with Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy.

Matsukuma K, Nishio S, Tasaki S, Park J, Nasu H, Yoshimitsu T, Tasaki K, Katsuda T, Terada A, Tsuda N, Sanada S, Ushijima K. Matsukuma K, et al. Among authors: nasu h. Kurume Med J. 2024 Mar 29. doi: 10.2739/kurumemedj.MS7012004. Online ahead of print. Kurume Med J. 2024. PMID: 38556270 Free article.

7

Comprehensive Molecular Profiling and Clinicopathological Characteristics of Gastric-Type Mucinous Carcinoma of the Uterine Cervix in Japanese Women.

Nasu H, Nishio S, Park J, Tasaki K, Terada A, Tsuda N, Kawano K, Kojiro-Sanada S, Akiba J, Ushijima K. Nasu H, et al. Kurume Med J. 2024 Feb 16. doi: 10.2739/kurumemedj.MS6934018. Online ahead of print. Kurume Med J. 2024. PMID: 38369337 Free article.

8

N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of Ovarian Cancer, in Its Association with Beta-Catenin.

Terada A, Tsuda N, Tasaki S, Park J, Nasu H, Tasaki K, Katsuda T, Nishio S, Yamaguchi T, Sanada S, Akiba J, Kuwano M, Ono M, Ushijima K. Terada A, et al. Among authors: nasu h. Kurume Med J. 2023 Nov 30;69(1.2):39-46. doi: 10.2739/kurumemedj.MS6912010. Epub 2023 Oct 3. Kurume Med J. 2023. PMID: 37793886 Free article.

9

Domestication of azuki bean and soybean in Japan: From the insight of archeological and molecular evidence.

Takahashi Y, Nasu H, Nakayama S, Tomooka N. Takahashi Y, et al. Among authors: nasu h. Breed Sci. 2023 Apr;73(2):117-131. doi: 10.1270/jsbbs.22074. Epub 2023 Apr 27. Breed Sci. 2023. PMID: 37404345 Free PMC article.

10

Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601.

Ito K, Nakagawa M, Shimokawa M, Hori K, Tashima L, Goto M, Yanagida S, Suzuki J, Kaya R, Kawabata A, Yamada K, Park J, Nasu H, Nishio S, Kondo E, Kaneda M, Tsubamoto H, Arakawa A, Nagasawa T, Motohashi T. Ito K, et al. Among authors: nasu h. Anticancer Drugs. 2023 Aug 1;34(7):857-865. doi: 10.1097/CAD.0000000000001472. Epub 2022 Dec 5. Anticancer Drugs. 2023. PMID: 36729915 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page